PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 8 months ago Biophytis annonce les prochaines étapes règlementaires en Europe et aux Etats-Unis pour son projet COVA
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 9 months ago Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 9 months ago Biophytis obtient un avis positif pour son étude de phase 3 SARA-31 dans la sarcopénie en Europe
PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 9 months ago Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 9 months ago Biophytis a requis auprès de la FDA une réunion de pré-soumission d’Autorisation d’Utilisation d’Urgence de Sarconeos (BIO101) dans le traitement du COVID-19
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 9 months ago Biophytis annonce un Placement Direct Enregistré de 3,8 millions de dollars
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 9 months ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 9 months ago Biophytis et SEQENS signent un partenariat pour la production du principe actif de Sarconeos (BIO101)
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 9 months ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 9 months ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
Published on 05/08/2026 at 15:55, 5 hours 5 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 6 hours ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 6 hours 5 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 6 hours 30 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 7 hours ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 20:38, 22 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 hour 47 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 hour 58 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 1 hour ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 1 hour ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 1 hour ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 1 hour ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 2 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
